panuveitis

Search with Google Search with Bing
Information
Disease name
panuveitis
Disease ID
DOID:12030
Description
"An uveitis that is characterized by inflammation of all layers of the uvea (middle layer) of the eye, which includes the iris, ciliary body, and choroid." [url:https\://rarediseases.info.nih.gov/diseases/8577/panuveitis]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00167583 Completed Phase 3 Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB) November 2004 December 2014
NCT00404612 Completed Phase 3 A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis January 2007 May 2009
NCT00404742 Completed Phase 3 A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis January 2007 May 2009
NCT00404885 Completed Phase 3 A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis January 2007 May 2009
NCT00406887 Completed Phase 3 Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis August 2002 November 2003
NCT00407056 Completed Phase 3 Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis August 2002 June 2003
NCT02595398 Completed Phase 3 Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis November 17, 2015 January 18, 2018
NCT02725177 Completed N/A Ocular Sarcoidosis Open Label Trial of ACTHAR Gel July 2016 March 2022
NCT02746991 Completed Phase 3 Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis June 2, 2015 October 4, 2019
NCT02952001 Completed MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301 December 13, 2017 May 22, 2018
NCT03097315 Completed Phase 3 Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis April 4, 2017 January 24, 2018
NCT00615693 Completed Phase 2 Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis July 2008
NCT00908466 Completed Phase 1 Sirolimus as Therapeutic Approach to Uveitis July 2009 February 2013
NCT01789320 Completed Phase 1/Phase 2 Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis February 2013 March 2015
NCT02255032 Completed Phase 2 Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis October 2014 January 2016
NCT05101928 Recruiting Phase 4 Ozurdex Monotherapy Trial November 30, 2021 September 30, 2027
NCT06085079 Recruiting Phase 4 Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study June 1, 2022 December 30, 2024
NCT03656692 Terminated Phase 4 Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer) October 5, 2018 July 14, 2020
NCT00407316 Unknown status Quality of Life and Visual Function in Uveitis Patients June 2006 November 2006
NCT01280669 Withdrawn Phase 2 Intravitreal Sirolimus as Therapeutic Approach to Uveitis September 2022 December 2024
Disase is a (Disease Ontology)
DOID:13141
Cross Reference ID (Disease Ontology)
GARD:8577
Cross Reference ID (Disease Ontology)
ICD10CM:H44.11
Cross Reference ID (Disease Ontology)
ICD9CM:360.12
Cross Reference ID (Disease Ontology)
MESH:D015864
Cross Reference ID (Disease Ontology)
NCI:C84989
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:75614007
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0030343
Exact Synonym (Disease Ontology)
Diffuse uveitis
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0012121
MeSH unique ID (MeSH (Medical Subject Headings))
D015864